133 related articles for article (PubMed ID: 1892223)
21. Muscle histochemistry in congenital muscular dystrophy with central nervous system involvement.
Nonaka I; Sugita H; Takada K; Kumagai K
Muscle Nerve; 1982 Feb; 5(2):102-6. PubMed ID: 6461828
[TBL] [Abstract][Full Text] [Related]
22. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
Taniguchi M; Kurahashi H; Noguchi S; Fukudome T; Okinaga T; Tsukahara T; Tajima Y; Ozono K; Nishino I; Nonaka I; Toda T
Hum Mol Genet; 2006 Apr; 15(8):1279-89. PubMed ID: 16531417
[TBL] [Abstract][Full Text] [Related]
23. Duchenne dystrophy. I. Morphometric study of the muscle microvasculature.
Jerusalem F; Engel AG; Gomez MR
Brain; 1974 Mar; 97(1):115-22. PubMed ID: 4434164
[No Abstract] [Full Text] [Related]
24. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
25. Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane.
Matsubara S; Mizuno Y; Kitaguchi T; Isozaki E; Miyamoto K; Hirai S
Neuromuscul Disord; 1999 Oct; 9(6-7):388-98. PubMed ID: 10545042
[TBL] [Abstract][Full Text] [Related]
26. Degradation of connectin (titin) in Fukuyama type congenital muscular dystrophy: immunochemical study with monoclonal antibodies.
Matsumura K; Shimizu T; Sunada Y; Mannen T; Nonaka I; Kimura S; Maruyama K
J Neurol Sci; 1990 Sep; 98(2-3):155-62. PubMed ID: 2243226
[TBL] [Abstract][Full Text] [Related]
27. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy.
Kato R; Kawamura J; Sugawara H; Niikawa N; Matsumoto N
Am J Med Genet A; 2004 May; 127A(1):54-57. PubMed ID: 15103718
[TBL] [Abstract][Full Text] [Related]
28. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy.
Yamamoto T; Taniguchi-Ikeda M; Awano H; Matsumoto M; Lee T; Harada R; Imanishi T; Hayashi N; Sakai Y; Morioka I; Takeshima Y; Iijima K; Saegusa J; Toda T
Brain Dev; 2017 Nov; 39(10):861-868. PubMed ID: 28578814
[TBL] [Abstract][Full Text] [Related]
29. AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies.
Nagao H; Habara S; Morimoto T; Sano N; Takahashi M; Kida K; Matsuda H
Neuropediatrics; 1986 Nov; 17(4):193-8. PubMed ID: 3808228
[TBL] [Abstract][Full Text] [Related]
30. Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome.
Kimura S; Sasaki Y; Kobayashi T; Ohtsuki N; Tanaka Y; Hara M; Miyake S; Yamada M; Iwamoto H; Misugi N
Brain Dev; 1993; 15(3):182-91. PubMed ID: 8214343
[TBL] [Abstract][Full Text] [Related]
31. Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.
Beggs AH; Neumann PE; Arahata K; Arikawa E; Nonaka I; Anderson MS; Kunkel LM
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):623-7. PubMed ID: 1731332
[TBL] [Abstract][Full Text] [Related]
32. Fukuyama type congenital muscular dystrophy--two Dutch siblings.
Peters AC; Bots GT; Roos RA; van Gelderen HH
Brain Dev; 1984; 6(4):406-16. PubMed ID: 6496876
[TBL] [Abstract][Full Text] [Related]
33. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH
J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
[TBL] [Abstract][Full Text] [Related]
34. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
Connolly AM; Pestronk A; Planer GJ; Yue J; Mehta S; Choksi R
Neurology; 1996 Mar; 46(3):810-14. PubMed ID: 8618688
[TBL] [Abstract][Full Text] [Related]
35. Capillary circulation and morphology in Duchenne muscular dystrophy.
Leinonen H; Juntunen J; Somer H; Rapola J
Eur Neurol; 1979; 18(4):249-55. PubMed ID: 488143
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy.
Hino N; Kobayashi M; Shibata N; Yamamoto T; Saito K; Osawa M
Brain Dev; 2001 Mar; 23(2):97-107. PubMed ID: 11248458
[TBL] [Abstract][Full Text] [Related]
37. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K
Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional MR imaging of brain surface anomalies in Fukuyama-type congenital muscular dystrophy.
Toda T; Watanabe T; Matsumura K; Sunada Y; Yamada H; Nakano I; Mannen T; Kanazawa I; Shimizu T
Muscle Nerve; 1995 May; 18(5):508-17. PubMed ID: 7739638
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical alterations of dystrophin in congenital muscular dystrophy.
Werneck LC; Bonilla E
Arq Neuropsiquiatr; 1995 Sep; 53(3-A):416-23. PubMed ID: 8540815
[TBL] [Abstract][Full Text] [Related]
40. Blood vessel structure in Duchenne muscular dystrophy. I. Light and electron microscopic observations in resting muscle.
Koehler J
Neurology; 1977 Sep; 27(9):861-8. PubMed ID: 561343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
